Primrose syndrome: Characterization of the phenotype in 42 patients.
3-Hydroxyacyl CoA Dehydrogenases
/ genetics
Abnormalities, Multiple
/ genetics
Acetyl-CoA C-Acyltransferase
/ genetics
Adolescent
Adult
Calcinosis
/ genetics
Carbon-Carbon Double Bond Isomerases
/ genetics
Child
Child, Preschool
Ear Diseases
/ genetics
Enoyl-CoA Hydratase
/ genetics
Face
/ abnormalities
Female
Genetic Association Studies
Genetic Predisposition to Disease
Heterozygote
Humans
Infant
Intellectual Disability
/ genetics
Male
Megalencephaly
/ genetics
Middle Aged
Mitochondria
/ genetics
Muscular Atrophy
/ genetics
Mutation
Mutation, Missense
/ genetics
Nerve Tissue Proteins
/ genetics
Phenotype
Racemases and Epimerases
/ genetics
Testicular Neoplasms
Transcription Factors
/ genetics
Young Adult
ZBTB20
Primrose syndrome
alpha-fetoprotein
ectopic calcifications
overgrowth
Journal
Clinical genetics
ISSN: 1399-0004
Titre abrégé: Clin Genet
Pays: Denmark
ID NLM: 0253664
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
received:
26
01
2020
revised:
20
03
2020
accepted:
24
03
2020
pubmed:
9
4
2020
medline:
5
6
2021
entrez:
9
4
2020
Statut:
ppublish
Résumé
Primrose syndrome (PS; MIM# 259050) is characterized by intellectual disability (ID), macrocephaly, unusual facial features (frontal bossing, deeply set eyes, down-slanting palpebral fissures), calcified external ears, sparse body hair and distal muscle wasting. The syndrome is caused by de novo heterozygous missense variants in ZBTB20. Most of the 29 published patients are adults as characteristics appear more recognizable with age. We present 13 hitherto unpublished individuals and summarize the clinical and molecular findings in all 42 patients. Several signs and symptoms of PS develop during childhood, but the cardinal features, such as calcification of the external ears, cystic bone lesions, muscle wasting, and contractures typically develop between 10 and 16 years of age. Biochemically, anemia and increased alpha-fetoprotein levels are often present. Two adult males with PS developed a testicular tumor. Although PS should be regarded as a progressive entity, there are no indications that cognition becomes more impaired with age. No obvious genotype-phenotype correlation is present. A subgroup of patients with ZBTB20 variants may be associated with mild, nonspecific ID. Metabolic investigations suggest a disturbed mitochondrial fatty acid oxidation. We suggest a regular surveillance in all adult males with PS until it is clear whether or not there is a truly elevated risk of testicular cancer.
Identifiants
pubmed: 32266967
doi: 10.1111/cge.13749
pmc: PMC7384157
doi:
Substances chimiques
Nerve Tissue Proteins
0
Transcription Factors
0
ZBTB20 protein, human
0
fatty acid oxidation complex
0
3-Hydroxyacyl CoA Dehydrogenases
EC 1.1.1.-
Acetyl-CoA C-Acyltransferase
EC 2.3.1.16
Enoyl-CoA Hydratase
EC 4.2.1.17
Racemases and Epimerases
EC 5.1.-
Carbon-Carbon Double Bond Isomerases
EC 5.3.3.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
890-901Informations de copyright
© 2020 The Authors. Clinical Genetics published by John Wiley & Sons Ltd.
Références
Am J Med Genet A. 2017 Jul;173(7):1896-1902
pubmed: 28462983
Am J Physiol Endocrinol Metab. 2019 Feb 1;316(2):E268-E285
pubmed: 30601700
J Biol Chem. 2002 Mar 1;277(9):7598-609
pubmed: 11744704
Eur Urol. 2018 Jun;73(6):828-831
pubmed: 29433971
J Med Genet. 2014 Sep;51(9):605-13
pubmed: 25062845
Am J Med Genet A. 2016 Jun;170(6):1626-9
pubmed: 27061120
Nat Commun. 2016 Dec 20;7:13840
pubmed: 27996046
Oncotarget. 2016 Mar 22;7(12):14336-49
pubmed: 26893361
Ophthalmic Res. 2010;44(3):179-90
pubmed: 20829642
Am J Med Genet A. 2020 Mar;182(3):521-526
pubmed: 31821719
Biol Chem. 2013 Mar;394(3):393-414
pubmed: 23154422
Clin Dysmorphol. 2019 Jan;28(1):41-45
pubmed: 30256248
Clin Genet. 2020 Jun;97(6):890-901
pubmed: 32266967
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):3862-3872
pubmed: 31556767
Pediatr Hematol Oncol. 1998 Mar-Apr;15(2):135-42
pubmed: 9592840
J Ment Defic Res. 1986 Sep;30 ( Pt 3):301-8
pubmed: 3783663
Mol Cell Biol. 2009 May;29(10):2804-15
pubmed: 19273596
J Ment Defic Res. 1982 Jun;26 (Pt 2):101-6
pubmed: 6809950
Nat Rev Urol. 2016 Jul;13(7):409-19
pubmed: 27296647
Eur J Med Genet. 2006 Mar-Apr;49(2):127-33
pubmed: 16530709
Neurology. 2010 Jul 20;75(3):284-6
pubmed: 20644156
Nat Genet. 2014 Aug;46(8):815-7
pubmed: 25017102
Am J Med Genet A. 2018 May;176(5):1091-1098
pubmed: 29681083
Am J Med Genet A. 2019 Mar;179(3):344-349
pubmed: 30637921
Biochem Biophys Res Commun. 2001 Apr 13;282(4):1067-73
pubmed: 11352661
Development. 2015 Jan 15;142(2):385-93
pubmed: 25564625
Am J Med Genet A. 2011 Jun;155A(6):1379-83
pubmed: 21567911
Gastroenterology. 2012 Jun;142(7):1571-1580.e6
pubmed: 22374165
Am J Med Genet A. 2011 Nov;155A(11):2838-40
pubmed: 21910247
Sci Rep. 2015 Jul 15;5:11979
pubmed: 26173901
J Neurol. 2002 Oct;249(10):1466-8
pubmed: 12532939
Am J Med Genet A. 2019 Nov;179(11):2228-2232
pubmed: 31321892
Clin Dysmorphol. 1996 Jan;5(1):27-34
pubmed: 8867656
Hum Mutat. 2018 Jul;39(7):959-964
pubmed: 29737001
Nat Commun. 2015 Jan 22;6:5973
pubmed: 25609015
Circ Res. 2008 Feb 29;102(4):401-14
pubmed: 18309108